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DO YOU MIND MY SMOKING?  PLAIN PACKAGING OF 
CIGARETTES UNDER THE TRIPS AGREEMENT 
ALBERTO ALEMANNO & ENRICO BONADIO* 
INTRODUCTION 
“Plain packaging,” also known as “generic packaging,” is a new, yet untried, 
tobacco control policy tool.1  It requires that all forms of tobacco branding should be 
labelled exclusively with simple unadorned text.2  This entails that trade marks, 
graphics and logos be detached from cigarette packs, except for the brand name that 
is displayed in a standard font size, colour and location on the package.3  Moreover, 
the packaging should not contain colour and should include only the content and 
consumer information, such as toxic constituents, and health warnings required by 
law.4  In essence, plain packaging aims at standardizing the appearance of all 
cigarette boxes in order to make them unappealing, especially for adolescents, thus 
reducing the prevalence and up-take of smoking.5  
Some evidence shows that this innovative way of marketing tobacco products is 
likely to reduce tobacco consumption.6  In particular, studies show that plain 
packaging could attain such a result in two indirect, yet related, ways.7  It does not 
only contribute to make cigarettes look less attractive, but it also makes health 
warnings and information more visible.8  These studies claim that generic packaging, 
by increasing the effectiveness of health warnings and reducing misconceptions about 
the risks of smoking, might carry the potential to reduce smoking uptake, especially 
among children and young people, and accordingly protect human health.9  In 
particular, plain packaging is expected to play a valuable role in product perceptions 
                                                                                                                                                
* © Alberto Alemanno & Enrico Bonadio 2011.  Alberto Alemanno is an Associate Professor of 
Law at HEC Paris and Editor of the European Journal of Risk Regulations.  Enrico Bonadio is a 
Lecturer at City University London. 
1 See Becky Freeman, Simon Chapman & Matthew Rimmer, The Case for the Plain Packaging 
of Tobacco Products, 103 ADDICTION 4, 587 (2007) (stating that plain packaging is an important but 
underexplored part of tobacco control legislation). 
2 Id. at 581 (discussing the background and features of plain packaging). 
3 Id. 
4 Id. 
5 Id. at 581–82 (providing an overview of the features of generic packaging). 
6 Id. at 583 (reporting that plain packaging would reduce tobacco consumption for non-
smokers). 
7 Id. at 582–83. 
8 Id. 
9 Id.  See TNS Opinion & Social, Eurobarometer Special 332:  Tobacco, at 83 (May 2010), 
http://ec.europa.eu/health/tobacco/docs/ebs332_en.pdf (finding that smokers who believe some types 
of cigarettes are less risky for health focus on tar and nicotine levels, taste, terms in the brand’s 
name and colour of the packs).  See also Gerard Hastings, Karine Gallopel-Morvan & Juan Miguel 
Rey, The Plain Truth About Tobacco Packaging, 17 TOBACCO CONTROL 361, 361–62 (Nov. 28, 2008), 
available at http://tobaccocontrol.bmj.com/content/17/6/361.full.pdf?sid=69de25f8-f612-4f82-8db1-
17feb1154945 (noting that tobacco is addictive and risky but, contrary to drugs, does not provide any 
objective benefit). 
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and smoking initiation, effectively breaking the shift from experimentation to regular 
use.10 
Although the idea of plain packaging as an anti-tobacco policy tool is relatively 
new, it is already highly controversial.  Yet, as opposed to other tobacco policies, 
plain packaging has attracted not only limited public opinion attention, but also little 
academic scrutiny.  The aim of this article is to fill this gap, in particular in the 
international intellectual property literature, by focusing on the compatibility of 
plain packaging with the international system of trade mark protection as enshrined 
by the World Trade Organization’s Agreement on Trade Related Aspects of 
Intellectual Property (“TRIPS”).  As illustrated in the past by the Doha Declaration 
on the TRIPS Agreement and Public Health, a tension exists within this agreement 
between the protection of intellectual property rights (“IPRs”) and the public 
interest.11  The on-going plain packaging discussions belong to this debate and will 
inevitably represent a new ‘stress test’ for TRIPS.  After introducing the reader to the 
genesis and rationale of plain packaging, the focus of the article will shift to the legal 
status of this tobacco control tool under the international system for trade mark 
protection as enshrined in TRIPS and the Paris Convention for the Protection of 
Industrial Property. 
I. THE GENESIS OF PLAIN PACKAGING AND THE WORLD HEALTH ORGANIZATION’S  
FRAMEWORK CONVENTION ON TOBACCO CONTROL  
A majority of states have progressively acknowledged the need to regulate 
tobacco products as a result of the recognition of related adverse public health 
effects.12  As a result, over the years, a significant range of tobacco control measures 
have been adopted worldwide.13  More recently, these regulatory efforts have been 
codified within the World Health Organization (“WHO”) Framework Convention on 
Tobacco Control (“FCTC”), a multilateral treaty aimed at protecting “present and 
future generations from the devastating health, social, environmental and economic 
consequences of tobacco consumption and exposure to tobacco smoke.”14  To achieve 
this goal, the FCTC provides “a framework for tobacco control measures to be 
implemented by the Parties at the national, regional and international levels in order 
to reduce continually and substantially the prevalence of tobacco use and exposure to 
                                                                                                                                                
10 See G. Ferris Wayne & G. N. Connolly, How Cigarette Design Can Affect Youth Initiation 
into Smoking:  Camel Cigarettes 1983–93, 11 TOBACCO CONTROL i32, i37–38 (2002), available at 
http://tobaccocontrol.bmj.com/content/11/suppl_1/i32.full.pdf?sid=143cd297-f0a6-4b3e-b2ec-
305016ad64b8 (discussing the paradigm which plain packaging may eventually change). 
11 See Frederick M. Abbot, The DOHA Declaration on the TRIPS Agreement and Public Health:  
Lighting a Dark Corner at the WTO, 5 J. INT’L ECON. L. 469, 469–70 (2002). 
12 WORLD HEALTH ORG., IMPLEMENTING SMOKE-FREE ENVIRONMENTS, WHO REPORT ON THE 
GLOBAL TOBACCO EPIDEMIC 8 (2009), http://www.who.int/tobacco/mpower/2009/en/. 
13 Id. at 64. 
14 WORLD HEALTH ORG., WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL 5 (2003), 
http://whqlibdoc.who.int/publications/2003/9241591013.pdf [hereinafter FCTC] (noting that the 
FCTC became effective on 27 February 2005 and that the treaty, which is now closed for signature, 
has 168 Signatories, including the European Union, which makes it the most widely embraced 
treaty in UN history). 
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tobacco smoke.”15  Among the regulatory measures that the signatories shall 
implement, some of them are listed under Article 11 of the FCTC, “Packaging and 
labelling of tobacco products.”16  The Guidelines for Implementation of Article 11 
recommend the adoption of mandatory plain packaging.17 
The first record of discussions of generic packaging trace to Canada in 1986, 
when the Canadian Medical Association (“CMA”) proposed to have cigarettes sold in 
the equivalent of plain brown wrappers.18  The following year, the CMA called on the 
federal government to require that “tobacco products be sold in plain, standard-sized 
packages that state:  ‘This product is injurious to your health.”19  In January 1988m 
the idea was quickly taken up by some Canadian parliamentarians during discussion 
on the Tobacco Products Control Act.20  Yet, by that time, only a handful of policy 
makers or researchers had had an opportunity to evaluate its potential. 
Some countries have recently revived the debate by taking into serious 
consideration the opportunity of imposing generic packaging on tobacco products.  
Thus far, Australia is the most committed country to plain packaging.  Indeed, in 
August 2009, a bill was proposed to amend both Australia’s Trade Practices Act 1974 
and Trade Practices (Consumer Product Information Standards) (Tobacco) 
Regulations 2004 by changing product information standards and removing brands, 
trade marks and logos from tobacco packaging.21  This bill, which was buried by the 
dissolution of the Australian House of Representatives in September 2010, might be 
reintroduced in the new Parliament.22  In the meantime, in June 2009, the National 
Preventative Health Taskforce for the Minister for Health and Ageing released a 
report entitled “Australia:  The Healthiest Country By 2020,” which recommended 
the introduction of various tobacco-related measures, including plain packaging of 
cigarettes.23 
                                                                                                                                                
15 Id. 
16 Id. at 9. 
17 WORLD HEALTH ORG., GUIDELINES FOR IMPLEMENTATION OF ARTICLE 11 OF THE 
FRAMEWORK CONVENTION ON TOBACCO CONTROL, PACKAGING AND LABELLING OF TOBACCO 
PRODUCTS 46 (Nov. 17–22, 2008), http://www.who.int/fctc/guidelines/article_11.pdf. [hereinafter 
GUIDELINES 11]. 
 Parties should consider adopting measures to restrict or prohibit the use of 
logos, colours, brand images or promotional information on packaging other than 
brand names and product names displayed in a standard colour and font style 
(plain packaging).  This may increase the noticeability and effectiveness of health 
warnings and messages, prevent the package from detracting attention from 
them, and address industry package design techniques that may suggest that 
some products are less harmful than others. 
Id. 
18 ROB CUNNINGHAM, SMOKE & MIRRORS THE CANADIAN TOBACCO WAR 239 (1996). 
19 PHYSICIANS FOR SMOKE-FREE CANADA, THE PLOT AGAINST PLAIN PACKAGING 1–2 (Apr. 
2008), http://www.plain-packaging.com/Templates/BackgroundTemplate.aspx (outlining the Plain 
Packaging Time Line from June 1986 through 1999 including corresponding debate). 
20 Id.; CUNNINGHAM, supra note 18, at vii. 
21 Plain Tobacco Packaging (Removing Branding from Cigarette Packs) Bill 2009, 3–4 (Cth) 
(Austl.). 
22 See DEPT. OF THE SENATE, ODGERS’ AUSTRALIAN SENATE PRACTICE 262–64 (Harry Evans, 
ed., 12th ed. 2008), available at http://www.aph.gov.au/senate/pubs/odgers/pdf/odgers.pdf. 
23 Nat’l Preventative Health Taskforce for the Minister of Health & Ageing, Australia:  The 
Healthiest Country By 2020—National Preventative Health Strategies—the Roadmap for Action 19 
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Canada, the European Union (“EU”) and the United Kingdom are also 
considering laws mandating this marketing restriction.24  In particular, within the 
EU, following the launch of a public consultation on a possible revision of the Tobacco 
Products Directive,25 plain packaging is considered as one of the regulatory options 
aimed at reducing disparity in labelling throughout the EU, while at the same time 
promoting consumer information.26 
II. PLAIN PACKAGING AND ITS DISCONTENTS 
It does not come as a surprise that the tobacco industry is firmly against the 
introduction of generic packaging.  Additionally, as illustrated by the recent high 
number of submissions to the EU’s stakeholders’ consultation on the revision of the 
Tobacco Products Directive, many other industries are also concerned about the 
adoption of this policy option.27  In particular, besides a significant number of trade 
associations and trade owners linked to the tobacco industry, other industry 
sectors—especially those such as alcohol, food, confectionary, cosmetics, beverage and 
automotive, which are subject to significant regulatory constraints—are threatened 
by plain packaging.28 
First of all, opponents of plain packaging stress that generic packaging would 
not be very effective to the stated purpose of reducing smoking and protecting human 
health.29  To support this claim, it is often pointed out that there is a lack of evidence 
that generic packaging makes cigarette boxes less attractive to consumers, and also 
that more visible health warnings and information would induce smoking cessation.30  
                                                                                                                                                
(June 30, 2009), http://www.preventativehealth.org.au/internet/preventativehealth/publishing.nsf/ 
Content/nphs-roadmap/$File/nphs-roadmap.pdf. 
24 See generally U.K. Dept. of Health, A Smokefree Future:  A Comprehensive Tobacco Control 
Strategy for England, 39 (Feb. 1, 2010), http://www.dh.gov.uk/prod_consum_dh/groups/ 
dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_111789.pdf (introducing a report in which 
generic packaging has been examined in great detail).  
25 EUR. COMM’N HEALTH & CONSUMERS DIRECTORATE-GENERAL, PUBLIC CONSULTATION 
DOCUMENT ON POSSIBLE REVISION OF THE TOBACCO PRODUCTS DIRECTIVE 2001/37/EC, 7 (2010), 
http://ec.europa.eu/health/tobacco/docs/tobacco_consultation_en.pdf. 
26 Id. at 6–7. 
27 See id. at 8 (explaining that other industries, including manufacturers, have expressed 
concerns). 
28 See generally PHYSICIANS FOR SMOKE-FREE CANADA, supra note 19, at 11–30 (discussing the 
strategies to oppose plain packaging). 
29 Freeman, Chapman & Rimmer, supra note 1, at 584. 
30 See 26 June 2009, PARL. DEB., H.C. (2008) 305 (U.K.), available at 
http://www.publications.parliament.uk/pa/cm200809/cmpublic/health/090625/pm/90625s09.htm.  
The Minister of State for Public Health stated: 
There is some evidence that branding on cigarette packs may increase brand 
awareness among young people but it is not conclusive. . . . While there is also 
evidence to suggest that branding on packs may mislead customers about the 
relative safety of different tobacco products, that too is very limited. No studies 
have been undertaken to show that plain packaging of tobacco would cut smoking 
uptake among young people or enable those who want to quit to do so. Given the 
impact that plain packaging would have on intellectual property rights, we would 
undoubtedly need strong and convincing evidence of the benefits to health, as well 
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Plain packaging could even have a “boomerang” effect, i.e., it could increase smoking 
uptake as companies would be prompted to compete only on cigarette prices, making 
tobacco cheaper and more affordable for consumers, particularly among young 
people.31 
It is argued instead that other less invasive instruments would be far more 
effective than generic packaging in the struggle against smoking, such as educational 
campaigns, health information and warnings on cigarette boxes, among other 
options.32 
Finally, plain packaging would encourage the counterfeiting of tobacco 
products33 by:  (i) making it easier and less expensive to copy packaging; (ii) reducing 
trade mark holders’ ability to bring legal action against counterfeiters; and (iii) 
increasing the burden on enforcement agencies, which in turn would jeopardize 
consumers’ interests.34 
III. THE CLASH BETWEEN PLAIN PACKAGING AND TRADE MARK RIGHTS 
As is known, packaging is key to tobacco majors, particularly when it comes to 
targeting young people and first time customers.35  Unlike many other mass 
                                                                                                                                                
as its workability, before this could be promoted and accepted at an international 
level—especially as no country in the world has introduced plain packaging. 
Id.  See also IMPERIAL TOBACCO AUSTL. LTD., SUBMISSION TO THE SENATE:  PLAIN TOBACCO 
PACKAGING (REMOVING BRANDING FROM CIGARETTE PACKS) BILL 2009, 8–10 (Apr. 2010), 
http://www.imperial-tobacco.com/files/misc/submission_on_proposals.pdf; SENATE CMTY. AFFAIRS 
REFERENCE COMM., THE TOBACCO INDUSTRY AND THE COSTS OF TOBACCO-RELATED ILLNESS 70 
(Dec. 1995), http://www.aph.gov.au/SENATE/committee/clac_ctte/completed_inquiries/pre1996/ 
tobacco/report/report.pdf. 
 The Committee received a range of often conflicting evidence on the efficacy 
of generic packaging. While some evidence suggested that generic packaging 
would reduce the attractiveness of cigarettes for children, other evidence raised 
some doubts concerning the effectiveness of this approach. The Committee 
believes that more research needs to be undertaken into the role generic 
packaging could play in an integrated strategy addressing the problem of 
adolescent smoking. The Committee considers that, on the basis of the evidence 
received, there is not sufficient evidence to recommend that tobacco products be 
sold in generic packaging. 
Id. 
31 Freeman, Chapman & Rimmer, supra note 1, at 584. 
32 See generally IMPERIAL TOBACCO AUSTL. LTD., supra note 30, at 17–18. 
33 See id. at 27–28; see also Letter from Heather Steinmeyer, President, Int’l Trademark Ass’n. 
to Parliament House, Sec’y of Comm. on Cmty. Affairs (Feb. 24, 2010), http://www. 
aph.gov.au/senate/committee/clac_ctte/plain_tobacco_packaging_09/submissions/Sub20.pdf. 
34 See IMPERIAL TOBACCO AUSTL. LTD., supra note 30, at 34; see also BRITISH AM. TOBACCO, 
RESPONSE TO THE DEP’T. OF HEALTH “CONSULTATION ON THE FUTURE OF TOBACCO CONTROL, MAY 
2008” at 28–30 (Sept. 5, 2008); ANTI-COUNTERFEITING GRP., A JOINT RESPONSE, ¶¶ 16–17 (May 
2008), http://www.plain-packaging.com/downloads/Anti-Counterfeiting_Group_response_to_UK_ 
DOH_consultation.pdf. 
35 See generally When Packages Can’t Speak:  Possible Impacts of Plain and Generic Packaging 
of Tobacco Products (Mar. 1995), http://www.plain-packaging.com/downloads/Canada_Expert_ 
Panel_Report_-_When_Packages_Can%27t_Speak_Mar_95_-_excerpt.pdf.  A national survey of 
teens confirmed that “knowledge, beliefs, attitudes and images that consumers hold about products 
and brands are intervening variables that can be used to predict future purchase behaviours.”  Id. at 
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products, cigarette boxes remain with users once first opened and are continuously 
displayed in public, thus becoming a powerful and direct form of mobile advertising 
for the brand.36 
Plain packaging would remove all the fancy design elements from cigarette 
boxes, which usually influence consumers’ purchase decisions, and would break the 
link between producers and users.37  In particular, plain packaging would result in a 
ban on the use of all those graphic, fancy design elements and logos, so-called “trade 
dress” or “get up” of the product, which are protectable under international and 
national trade mark laws and are often registered as trade marks worldwide.38  
Under generic packaging, even the use of the brand name would be partially banned, 
since its distinctive typeface, colour and letter size would be replaced by a standard, 
plain format.39  The result would be a final product that would inevitably appear 
boring, daunting and lifeless to the eyes of consumers.40  As a result, generic 
packaging is likely to interfere with the two main functions of trade marks.41  First, 
it may jeopardize their function as “indication of origin,” in the sense of indication of 
company and trade origin.42  By definition, trade marks enable consumers to make 
simplified and educated purchase choices, thus reducing purchasing risks and 
ensuring consumer choice.43  This fundamental function cannot be fulfilled if trade 
marks are not visible, or even available, to consumers when selecting a product.  
Indeed, plain packaging as applied to cigarettes may threaten consumers’ ability to 
make reasoned choices, as there would be little difference between the cigarette 
                                                                                                                                                
55.  With particular reference to tobacco products, this report found that “packaging is an important 
cue in brand identification for Canadian teens.  Even teens who are not committed to smoking 
yet . . . can identify several brands solely on the basis of package cues only, that is, with no brand 
name associated with the package.  Package design alone, without brand name, provides enough 
information for almost all teens to recognize the two top teen cigarette brands in the Canadian 
market.”  Id. at 75. 
36 See Freeman, Chapman & Rimmer, supra note 1, at 580. 
37 Id. at 581. 
38 Council Regulation 207/09, 2009 O.J. (L 78) 2–3 (EU) (noting that the subject matter 
protectable by registration is broad).  Further, a “[c]ommunity trade mark may consist of any signs 
capable of being represented graphically, particularly words, including personal names, designs, 
letters, numerals, the shape of goods or of their packaging.”  Id. at art. 4; see Council Regulation 
2008/95, 2008 O.J. (L 299) 26 (EU); TRIPS, infra note 63, art 15. 
39 Angela Paladino, Assoc. Professor Dep’t of Mgmt. and Mktg. at U. Melbourne, The Impact of 
Packaging on Brands—The Case of Cigarettes, Address at the Intellectual Property Research 
Institute of Australia Seminar Melbourne (May 26, 2010); see also Freeman, Chapman & Rimmer, 
supra note 1, at 581. 
40 Freeman, Chapman & Rimmer, supra note 1, at 582. 
41 See GUY TRITTON, INTELLECTUAL PROPERTY IN EUROPE 225–26 (3d ed. 2008) (explaining the 
two main, and complimenting, functions of a trade mark (1) “it enables a consumer to distinguish 
between goods from differing sources,” and (2) it is essential that “the owner of the mark has the 
exclusive right to market goods or services which are protected under the mark”). 
42 Id. at 227; see also Freeman, Chapman & Rimmer, supra note 1, at 583 (providing examples 
of when packaging is used as an indication of origin). 
43 Case C-349/95, F. Loendersloot Internationale Expeditie v. George Ballantine & Son Ltd, 
1997 E.C.J. I-6253 (explaining the function of trade marks as indication of origin in its ruling in this 
re-packaging case and stating that “account must be taken of the essential function of the trade 
mark, which is to guarantee to the consumer or end user the identity of the trade-marked product’s 
origin by enabling him to distinguish it without any risk of confusion from products of different 
origin”). 
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boxes marketed by individual tobacco companies.  As a result, this measure would 
prevent tobacco trade marks from serving their institutional purpose, which is to 
help consumers distinguish the products of an undertaking which consumers know 
and trust from those of another unknown competitor.44  Rather, consumers would get 
confused as to the trade origin and quality of cigarettes.45 
Secondly, plain packaging may jeopardize the function of trade marks as 
“conveyor of messages.”46  Indeed, very often consumers make purchase choices 
relying on the “brand image” of the trade mark, regardless of the features of the 
product on which such sign is affixed.47  Tobacco products are no exception to that—
their brand image is often more important to today’s image-conscious public than the 
underlying product.48  As generic packaging requires the total removal of the fancy 
market appeal elements from cigarettes boxes, it may deprive tobacco trade marks of 
their overall “brand image,” and thus seriously jeopardize the goodwill which is 
usually attached to these brands.49 
An interesting case from the 1990s confirms the relevance of “brand image” in 
the mass market products and of packaging trade dress in general.  This case 
regarded marketing of infant formula milk in Guatemala.50  More precisely, in 1983 
this country implemented the WHO/United Nations Children’s Fund (“UNICEF”) 
International Code of Marketing of Breast-Milk Substitutes, which inter alia, 
prohibited the use of images of babies on foods destined for children under the age of 
two.51  The goal of this legislative move was to protect the lives of infants by 
promoting breast-feeding over breast milk substitutes, and particularly to counter 
aggressive marketing by baby food companies aimed at convincing mothers that their 
products were superior to breast milk for their babies.52  Indeed, the law specifically 
banned images that idealized the products in question.53  Facing its implementation, 
the U. S. children’s food company, Gerber, claimed such law infringed its trade mark, 
                                                                                                                                                
44 See generally Imperial Tobacco Austl. Ltd., supra note 30, at 3, 25, 32 (noting that concerns 
have also been raised by retailers, who stress that such a marketing restriction would make them 
waste valuable time to recognize the different brands requested by their clients); see also Tim 
Wilson, Dir. Intellectual Property & Free Trade Unit, Inst. Pub. Affairs, The Cost of Plain 
Packaging?, Address at the Intellectual Property Research Institute of Australia Seminar 
Melbourne (May 26, 2010) (explaining concerns raised by others and related legal implications). 
45 Imperial Tobacco Austl. Ltd., supra note 30, at 19, 22 (noting that one might argue that 
confusion on the part of the public would not occur as generic packaging still permits to brands to 
keep names on the product, although in a standardized format and deprived of its fancy elements).  
46 See, e.g., Tritton, supra note 41, at 227 (explaining the function of trade marks as conveyor of 
“psychological messages”). 
47 Freeman, Chapman & Rimmer, supra note 1, at 581–82 (noting that distinguishing 
packaging is particularly important in market categories like cigarettes, where goods or services 
tend to be homogeneous). 
48 See id. 
49 See id. at 585 (noting that special requirements for tobacco trademarks are justifiable “in 
order to reduce good-will associated to those marks and thus limit their power to induce 
consumption”).  
50 Russell Mokhiber, Gerber Uses Threat of GATT Sanctions To Gain Exemption from 
Guatemalan Infant Health Law, 10 CORP. CRIME REP. 14, ¶ 6–7 (1996). 
51 Id. ¶ 3–4 (noting that in 1983 Guatemala became one of the first countries to implement the 
International Code of Marketing of Breast Milk Substitutes); see World Health Assembly, May Res. 
34.22, International Code of Marketing of Breastmilk Substitutes, 14th Mtg. (May 21, 1981). 
52 Mokhiber, supra note 50, ¶ 3–4. 
53 Id. ¶¶ 5–6. 
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which included the image of a healthy and rather fat baby.54  Gerber then began 
threatening Guatemala to lobby the U.S. State Department with a view of imposing 
trade sanctions under the General Agreement on Tariffs and Trade (“GATT”) and 
other trade measures, in particular, lodging complaints with the U.S. Generalized 
Systems of Preferences.55  This move prompted the Guatemalan Supreme Court to 
exclude the application of that law to imported products, such as those imported by 
Gerber.56 
IV. PLAIN PACKAGING UNDER THE TRIPS AGREEMENT 
We have seen that plain packaging of cigarettes might interfere with the two 
main functions of trade marks, thus jeopardizing the goodwill that is usually 
attached to these signs.  This potential interference is prompting the tobacco 
industry, and other regulated industries, to jump to the defence of their IPRs.  
Indeed, one of the most threatening arguments against plain packaging is its alleged 
incompatibility with the international system of trade mark protection as enshrined 
by TRIPS.57  In particular, plain packaging could contravene several TRIPS 
provisions on trade marks,58 thus any country that adopts this regulatory measure 
might expose itself to the dispute settlement proceedings initiated by other members 
within the framework of the World Trade Organization (“WTO”).59  TRIPS is one of 
                                                                                                                                                
54 Id. ¶ 5. 
55 Id. ¶¶ 7–8.  Frank T. Kelly, Gerber's Vice President for Latin America, wrote to the 
president of Guatemala stating that, 
[u]pon the favorable and permanent resolution of this matter, we will withdraw 
all complaints before the CBI [Caribbean Basin Initiative], GATT and any other 
future instance before the authorities of the General System of 
Preferences. . . . We will be prepared to reactivate the defense of our efforts for our 
rights before the CBI, GATT, and in the Congress of the United States of America 
if a final and favorable resolution is not reached in the short term. 
Id. 
56 Id. ¶ 8; Robert N. Mayer, Protectionism, Intellectual Property and Consumer Protection:  Was 
the Uruguay Round Good for Consumers?, 21 J. CONSUMER POL’Y 195, 209 (1998). 
57 Freeman, Chapman & Rimmer, supra note 1, at 585. 
58 ASS’N INTERNATIONALE POUR LA PROTECTION DE LA PROPRIÉTÉ INTELLECTUELLE, PUBLIC 
CONSULTATION ON THE POSSIBLE REVISION OF THE TOBACCO PRODUCTS DIRECTIVE 2001/37/EC, 4 
(Dec. 17, 2010).  As far as the European dimension is concerned, it is also believed that plain 
packaging might violate Article 1 of the First Protocol to the European Convention on Human 
Rights.  Id. at 3 (noting that Anheuser-Busch v Portugal, 44 Eur. H.R. Rep. 42 (2007), gave a broad 
interpretation of this provision, stressing that it also applies to IPRs, including trade marks, and 
that an application for trade mark registration is a substantive interest protected by Article 1 as it 
creates rights of a proprietary nature).  Article 1 provides that anyone “is entitled to the peaceful 
enjoyment of his possessions” and cannot be deprived of said possessions.  Convention for the 
Protection of Human Rights and Fundamental Freedoms, art. 1, Nov. 4, 1950, 312 U.N.T.S. 13; see 
also Christopher Morcom, Trademarks, Tobacco and Human Rights, 210 TRADEMARK WORLD 20, 20 
(2008). 
59 See generally IMPERIAL TOBACCO AUSTL. LTD., supra note 30, at 24–26 (noting that TRIPS is 
administered by WTO and TRIPS incorporates parts of The Paris Convention for the Protection of 
Industrial Property 1888 which is administered by the World Intellectual Property Organization 
(WIPO) and if the plain packaging bill is enacted it would be subject to challenges by both WTO and 
WIPO). 
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the WTO Agreements signed in 1994 at the end of the Uruguay Round and is one of 
the pillars of the multilateral trade system.60  TRIPS imposes on WTO Members the 
obligation to ensure a minimum level of protection of all types of IPRs, including 
trade marks.61  
In particular, critics argue that plain packaging may violate Articles 17, 20 and 
15(4) of TRIPS and Article 6 quinquies (B) of the Paris Convention, which is 
incorporated by reference into TRIPS pursuant to its Article 2(1), and could not be 
justified under Article 8(1) of the same treaty.62 
The next sections provide an analysis of the TRIPS-compatibility of plain 
packaging by following an article-by-article approach.  After illustrating the 
arguments that can be developed against plain packaging measures, the focus of the 
analysis will shift to the possibility of accommodating those marketing restrictions 
within the TRIPS provisions. 
A. TRIPS—Article 17 
Article 17 of TRIPS states that “[m]embers may provide limited exceptions to 
the rights conferred by a trade mark, such as fair use of descriptive terms, provided 
that such exceptions take account of the legitimate interests of the owner of the trade 
mark and of third parties.”63 
States are therefore permitted to limit the exclusive rights of trade mark 
holders. Yet such exceptions should be “limited.”64  The first useful interpretation of 
the term “limited exceptions” to IPRs was given by a WTO Panel in a patent-related 
                                                                                                                                                
60 Agreement on Trade-Related Aspects of Intellectual Property Rights, Marrakesh Agreement 
Establishing the World Trade Organization, Annex 1C, Legal Instruments—Results of the Uruguay 
Round, art. 17, Apr. 15, 1994, 33 I.L.M. 1125, 1869 U.N.T.S. 299 [hereinafter TRIPS], available at 
http://www.wto.org/english/docs_e/legal_e/27-trips.pdf; Danielle Tully, Prospects for Progress:  The 
Trips Agreement and Developing Countries after the Doha Conference, 26 B.C. INT’L & COMP. L. 
REV. 129, 134 (2003). 
61 See generally, MICHAEL BLAKENEY, TRADE RELATED ASPECTS OF INTELLECTUAL PROPERTY 
RIGHTS:  A CONCISE GUIDE TO THE TRIPS AGREEMENT (1996) (discussing the TRIPS agreement); see 
generally JAYASHREE WATAL, INTELLECTUAL PROPERTY RIGHTS IN THE WTO AND DEVELOPING 
COUNTRIES 291–332 (2001) (discussing international intellectual property rights);  CARLOS CORREA, 
TRADE RELATED ASPECTS OF INTELLECTUAL PROPERTY RIGHTS 8 (2007) (discussing TRIPS). 
62 Letter from Lalive Law Firm to Philip Morris Int’l Mgmt. 5 (July 23, 2009) [hereinafter 
Lalive Opinion], available at http://www.plain-packaging.com/downloads/LALIVE_Analysis_23_ 
July_2009.pdf; see also TIM WILSON, INST. OF PUB. AFFAIRS, GOVERNING IN IGNORANCE:  
AUSTRALIAN GOVERNMENTS LEGISLATING, WITHOUT UNDERSTANDING, INTELLECTUAL PROPERTY 
16–19 (May 2010), http://www.ipa.org.au/library/publication/1275976632_document_100508_- 
_paper_-_governing_in_ignorance.pdf. 
63 TRIPS, supra note 60, at art. 17. 
64 CORREA, supra note 61, at 193–95 (exploring the meaning of “limited exceptions”).  Correa 
stresses that TRIPS Article 17 echoes the wording of Articles 13 and 30 of the same treaty, without 
encompassing any three-step test like that required by Article 6bis of the Paris Convention.  Id. at 
194; see also Watal, supra note 61, at 259 (exploring various exceptions to the rights conferred in a 
trademark); NUNO PIRES DE CARVALHO, THE TRIPS REGIME OF TRADEMARKS AND DESIGN 296 
(2006) (exploring the three step test in Article 17 that exceptions must pass in order to be TRIPS-
consistent:  “the exception must be limited; they must take account of the legitimate interests of the 
owner; and they must take account of the interests of third parties.”). 
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dispute.65  This occurred in Canada—Patent Protection for Pharmaceutical 
Products,66 when the Panel was called upon to interpret Article 30 of TRIPS, which 
contains a patent-related exception similar to Article 17.67  On that occasion, the 
Panel gave a narrow interpretation of this provision.68  It held that the word 
“exception” by itself connotes a “limited derogation, one that does not undercut the 
body of rules from which it is made. . . . The term ‘limited exception’ must therefore 
be read to connote a narrow exception—one which makes only a small diminution of 
the rights in question.”69  It is undisputed that this interpretation of “limited 
exceptions” also applies to trade marks.70  This was later confirmed by another WTO 
Panel in European Communities—Trade marks and Geographical Indications for 
Agricultural Products and Foodstuffs.71  Indeed, it should be noted that the 
exceptions to IPRs, whether trade mark, copyright or patent rights, are meant to 
meet analogous aims, i.e., to guarantee limited areas of freedom to IPRs holders’ 
competitors and third parties in good faith, and thus to pursue relevant public 
policies.72 
(i) This interpretation of Article 17 seems to comfort, at least prima facie, the 
critics of plain packaging.  Indeed, in light of the above disputes, one may argue that 
generic packaging cannot be justified as a “limited exception” to trade mark rights as 
this restrictive measure implies the quasi–nullification of such rights.73  What seem 
to be allowed under Article 17 of TRIPS are only very narrow exceptions, which do 
not annihilate the rights of trade mark owners such as the fair use of descriptive 
terms by third parties.74 
                                                                                                                                                
65 See generally Panel Report, Canada—Patent Protection for Pharmaceutical Products, 
WT/DS114/R 8 (Mar. 17, 2000) [hereinafter Canada—Patent] (noting that sections of the Patent Act 
conform with Canada’s obligations under TRIPS because the provisions are “limited exceptions” to 
the rights conferred by a patent within the meaning of Article 30 of TRIPS); see also Watal, supra 
note 61, at 259 (noting that Article 17 of TRIPS follows the language of Article 13 for copyrights and 
Article 30 for patents). 
66 Canada—Patent, supra note 65. 
67 Id. at 20–21 (stating that Article 30 TRIPS states that “[m]embers may provide limited 
exceptions to the exclusive rights conferred by a patent, provided that such exceptions do not 
unreasonably conflict with a normal exploitation of the patent and do not unreasonably prejudice 
the legitimate interests of the patent owner, taking account of the legitimate interests of third 
parties.”). 
68 See Pires de Carvalho, supra note 64, at 296 (discussing the Canada—Patent Panel Report, 
supra note 65). 
69 Canada—Patent, supra note 65, at 155; see also R. Howse, The Canadian Generic Medicines 
Panel—A Dangerous Precedent in Dangerous Times, 3 J. WORLD INTELL. PROP. 493, 497 (2000) 
(discussing the Canada—Patent Panel Report, supra note 65). 
70 Panel Report, European Comm’ns—Protection of Trademarks and Geographical Indications 
for Agric. Products and Foodstuffs, WT/DS174R 143 (Mar. 15, 2005) [hereinafter Protection of 
Trademarks]. 
71 Id. 
72 See, e.g., TRIPS, supra note 63, at art. 17 (cautioning that exceptions to private rights should 
take into account the interests of third parties). 
73 Wilson, supra note 62, at 16–17. 
74 See, e.g., Council Directive 2008/95, art. 6, 2008 O.J. (L 299) 25, 29 (EU).  The directive 
states that trade mark holders cannot prevent a third party from using in the course of trade:   
(a) his own name or address; (b) indications concerning the kind, quality, 
quantity, intended purpose, value, geographical origin, the time of production of 
goods or of rendering of the service, or other characteristics of goods or services; 
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(ii) It could be further argued that plain packaging does not take into account 
the legitimate interests of trade mark holders and therefore violates Article 17 of 
TRIPS.75  To unfold this argument, it is worth exploring the meaning of “legitimate 
interests of the owner of the trade mark.”76  In another dispute, EC—Trade marks 
and Geographical Indications, the WTO Panel defined that expression as follows:  
[e]very trade mark owner has a legitimate interest in preserving the 
distinctiveness, or capacity to distinguish, of its trade mark so that it can 
perform that function. This includes its interest in using its own trade mark 
in connection with the relevant goods and services of its own and authorized 
undertakings. Taking account of that legitimate interest will also take 
account of the trade mark owner's interest in the economic value of its mark 
arising from the reputation that it enjoys and the quality that it denotes. 77 
By stating the above, the Panel basically held that trade marks should not be 
prevented from serving their basic functions as both “badge of trade origin” and 
“conveyor of messages.”78  As already shown, the latter function has become 
particularly important, as much of the economic value of trade marks—especially 
well known trade marks—arises more frequently from extra-product and 
psychological features than ever before.79 
By relying on the above interpretation, one could argue that plain packaging, 
unlike more benign exceptions such as descriptive fair use of another’s trade marks, 
totally prevents the use of cigarette trade marks.  This interpretation would 
jeopardize the “legitimate interests” of right owners, and particularly both functions 
of trade marks.80  Indeed, by adopting plain packaging (a) right holders would be 
prevented from distinguishing their tobacco products from those of their competitors 
and (b) all the economic value of their trade marks, which mostly stems from the 
reputation they acquired on the markets and the quality message associated with 
them, would be annulled.81 
(iii) From the above interpretation, one could also argue that generic packaging 
jeopardizes the legitimate interests of third parties, i.e., consumers.82  Indeed, the 
function of trade marks as “indication of trade origin” is served not only for rights 
owners, but also for consumers who have a legitimate interest in being able to 
                                                                                                                                                
(c) the trade mark where it is necessary to indicate the intended purpose of a 
product or service, in particular as accessories or spare parts; provided he uses 
them in accordance with honest practices in industrial or commercial matters. 
Id.  See also Council Regulation 207/09, art. 12, 2009 O.J. (L 78) 1, 5 (EU) (identifying what a third 
party is entitled to know regarding a Community trade mark). 
75 Wilson, supra note 62, at 16–17. 
76 TRIPS, supra note 63, at art. 17. 
77 Protection of Trademarks, supra note 71, at 147. 
78 See, e.g., Tritton, supra note 41, at 227 (explaining the function of trade marks as conveyor of 
“psychological messages”); see also AMANDA MICHAELS, A PRACTICAL GUIDE TO TRADEMARK LAW 2 
(3d ed. 2002) (noting that a trademark is seen as a badge of honor which carries an implied 
assurance of quality).  
79 See Tritton, supra note 41, at 227. 
80 Pires de Carvalho, supra note 64, at 296. 
81 See Lalive Opinion, supra note 62, at 9–10. 
82 Imperial Tobacco Austl. Ltd., supra note 30, at 31–32. 
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distinguish the goods and services of one undertaking from those of another, and 
thus to avoid confusion.83  Yet, in the case of plain packaging, the distinctive 
elements of tobacco trade marks would be removed and, accordingly, consumer 
confusion is likely as to the trade origin of cigarettes. 
Most of these arguments, however, can be countered by looking both at the 
language employed by TRIPS and at the overall rationale and content of IPRs. 
For example, in response to the first argument noted above, one may argue that 
generic packaging is limited as it does not authorize third parties to exploit tobacco 
trade marks, and therefore right holders could still exercise the most important right 
granted to them, i.e., prohibiting third parties from misappropriating their trade 
marks.84  Indeed, in other TRIPS-related cases that involved this kind of exception 
(i.e., Article 13 on copyright, Article 30 on patents and Article 17 on trade marks), the 
issue was whether third parties other than the copyright, patent or trade mark 
owner were free to use the intellectual property asset without the consent of the IPR 
owner.85  It is undisputed that plain packaging does not allow third parties to 
(mis)use tobacco majors’ trade marks, but it is merely a restriction on right owners’ 
ability to use their own trade marks.86  Under such circumstances, it can be argued 
that the curtailment of the exclusive trade marks rights is “limited” and there is no 
violation of TRIPS Article 17. 
Moreover, it may be observed that Article 17 makes reference to “exceptions to 
the rights conferred by a trade mark.”87  One should therefore verify which rights are 
offered by TRIPS to trade mark holders.  The provision to look at is Article 16(1) of 
TRIPS, which is to be read in conjunction with Article 17.88  A joint reading of these 
provisions might offer an overall interpretation of TRIPS trade mark-related 
provisions which supports plain packaging. 
Article 16(1) enshrines a well known principle of trade mark law and generally 
of intellectual property law:89  IPRs and particularly trade mark rights do not offer 
their owners a positive right to actually use the protected asset (for example, a fancy 
sign), but just a ius excludendi alios, i.e., the negative right to prevent third parties 
from using the asset in question.90  It would follow that generic packaging cannot be 
deemed under Article 17 of TRIPS as an “exception to the rights conferred by a trade 
mark,” as no positive right to use trade marks is offered by TRIPS to trade mark 
                                                                                                                                                
83 See, e.g., Protection of Trademarks, supra note 71, at 143–47. 
84 Wilson, supra note 62, at 17. 
85 See, e.g., Panel Report, United States—Section 110(5) of US Copyright Act, WT/DS160/R 31 
(June 15, 2000); Canada—Patent, supra note 65, at 147, 154; Protection of Trademarks, supra note 
71, at 147. 
86 See Wilson, supra note 62, at 17. 
87 TRIPS, supra note 63, at art. 17. 
88 Id. at arts. 16(1), 17. 
89 Id. at art. 16(1).  Article 16(a) states: 
[t]he owner of a registered trade mark shall have the exclusive right to prevent all 
third parties not having the owner’s consent from using in the course of trade 
identical or similar signs for goods or services which are identical or similar to 
those in respect of which the trade mark is registered where such use would result 
in a likelihood of confusion. 
Id. 
90 See id.; Lalive Opinion, supra note 62, at 15–16. 
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holders.91  Therefore, the question remains whether plain packaging could be 
implemented without amounting to an exception to the (negative) right to exclude 
third parties from exploiting the trade marks in question, as enshrined in Article 
16(1).92  As already mentioned, the marketing restriction in question does not 
prevent rights owners from enforcing their rights against infringers, but just entails 
that rights holders are unable to use their own trade marks.  It would, therefore, 
seem that generic packaging can be implemented without violating Article 16(1) and 
thus be considered lawful.93 
B. TRIPS—Article 20 
Article 20 of TRIPS states that: 
[t]he use of a trade mark in the course of trade shall not be unjustifiably 
encumbered by special requirements, such as use with another trade mark, 
use in a special form or use in a manner detrimental to its capability to 
distinguish the goods or services of one undertaking from those of other 
undertakings.94 
Thus, no interference with the use of the trade mark should be allowed, unless it 
is a justifiable encumbrance.  The aim of Article 20 is to outlaw special requirements 
making the use of trade marks difficult in the course of trade.95  For example, before 
TRIPS, some developing countries, including Brazil, Mexico and India, sought to 
strengthen the contractual power of local licensees vis-à-vis foreign partners, and 
requested that the licensed trade mark be used together with the sign used by the 
former.  Such measures now would not be permitted under Article 20 of TRIPS.96 
Once a measure has been ascertained as being a special requirement under this 
provision, it is necessary to verify whether such requirement is justified.  Article 20 
provides a list of prima facie forms of unjustifiable special requirements.97  For 
example, pursuant to this provision, limiting the size of drugs’ trade marks in order 
to give prominence to their generic name would be justifiable on public health 
grounds.98 
                                                                                                                                                
91 See Andrew Mitchell, Australia’s Move to the Plain Packaging of Cigarettes and its WTO 
Compatibility, 5 ASIAN J. WTO & INT’L HEALTH L. & POL’Y 405, 416 (2010), available at 
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1667746; see also Benn McGrady, TRIPS and 
Trademarks:  The Case of Tobacco, 3 WORLD TRADE REV. 53, 66–67 (2004). 
92 See TRIPS, supra note 63, at art. 16(1); see also Pires de Carvalho, supra note 64, at 262, 
301. 
93 See McGrady, supra note 91, at 66–67. 
94 See TRIPS, supra note 63, at art. 20. 
95 Lalive Opinion, supra note 62, at 10–11. 
96 See Correa, supra note 61, at 199; Watal, supra note 61, at 251; DANIEL GERVAIS, THE 
TRIPS AGREEMENT:  DRAFTING HISTORY AND ANALYSIS 116–17. 
97 See Gervais, supra note 61, at 116–17; see also Pires de Carvalho, supra note 64, at 330–31. 
98 See Watal, supra note 61, at 251–52 (noting that under Mexican Health Law the display of 
generic names, together with trademarks, on pharmaceutical products is compulsory and considered 
a justifiable special requirement). 
[10:450 2011] The John Marshall Review of Intellectual Property Law 464 
 
A WTO Panel interpreted Article 20 in Indonesia—Certain Measures Affecting 
the Automobile Industry, a case regarding the use of trade marks in the car 
industry.99  The United States objected to “Indonesia’s grant of ‘national motor 
vehicle’ benefits only to motor vehicles bearing a unique Indonesian trade mark 
owned by Indonesian nationals.”100  The Untied States maintained that such a 
requirement discriminated against foreign-owned trade marks and their owners and 
was also inconsistent with Article 20.101  The Panel, however, found no violation of 
this TRIPS provision.102  It stressed that the Indonesian benefit program did not 
“impose” any trade mark-related requirement, as foreign car companies entered into 
cooperation agreements with Indonesian enterprises on a voluntary basis and with 
the knowledge that the use of their sign would be restricted.103 
Given that, one could maintain that prohibiting or restricting the use of tobacco 
trade marks on cigarettes boxes would be an unjustifiable special requirement falling 
within the scope of Article 20.104  In particular, it could be observed that generic 
packaging is detrimental to tobacco trade marks’ capability to distinguish the goods 
on which they are attached insofar as such trade marks could not be used at all, 
except for the brand name in a standardized and neutral form.105  As shown above, 
this would jeopardize one of the two main functions of trade marks.  Moreover, it is 
true that plain packaging also requires the brand name to be used “in a special form,” 
i.e., such name should (i) be written in a standard form, (ii) be of a particular font 
and (iii) have letters of a specified size,106 which would confirm that this marketing 
restriction falls within the scope of Article 20. 
Plain packaging requirements could also be considered “justifiable” and not 
contrary to the provision in question, as they could be considered necessary to reduce 
smoking and protect human health.107  In particular, a state keen in protecting its 
citizens’ health may label these requirements as reasonable measures consistent 
with the purpose of promoting consumers’ welfare.108  That might seem a valid 
argument.  Still, it could be countered by stressing again that generic packaging, 
which will eliminate tobacco trade marks’ distinctiveness, would cause confusion on 
the part of consumers, thus jeopardizing another public interest just as important as 
public health protection. 
It can be further observed that Article 20 outlaws just positive encumbrances on 
the use of trade marks (e.g., an obligation on foreign owners to use their trade marks 
together with the signs of local licensees), but not those requirements restricting or 
                                                                                                                                                
99 See generally Panel Report, Indonesia—Certain Measures Affecting the Automobile Industry, 
WT/DS54/R, WT/DS55/R, WT/DS59/R, WT/DS64/R (July 2, 1998). 
100 Id. at 18, 321. 
101 Id. at 18. 
102 Id. at 324. 
103 Id. at 397; see CORREA, supra note 61, at 201. 
104 See Lalive Opinion, supra note 62, at 10; see Annette Kur, The Right to Use One’s Own 
Trade Mark:  A Self-evident Issue or a New Concept in German, European, and International Trade 
Mark Law?, 18 EUR. INT’L PROP. REV. 198, 202 (1996); see also Anselm Kamperman Sanders & 
Spyros M. Maniatis, A Quixotic Raid Against the Tobacco Mill, 19 EUR. INT’L PROP. REV. 237, 238 
(1997) (citing Kur’s argument). 
105 See Lalive Opinion, supra note 62, at 11. 
106 Id. 
107 See Mitchell, supra note 91, at 413. 
108 See Pires de Carvalho, supra note 64, at 330. 
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prohibiting the use of the sign.109  Indeed, Article 20 should be read in conjunction 
with Article 16(1) of TRIPS, which, as shown above, does not offer trade mark holders 
the positive right to use a trade mark.110  It follows that Article 20 cannot be 
interpreted as creating what other TRIPS provisions do not create—a positive right 
to use trade marks and it therefore cannot be invoked to oppose a prohibition or 
restriction of said use.111  In other terms, Article 20 would prohibit measures that 
govern how trade marks may be used, but not those measures which govern when 
and where trade marks can be used.112  The result is that the marketing restriction in 
question would be lawful. 
The above counter-argument seems to have its merits, as many countries in the 
context of public health protection programs have implemented advertising 
restrictions, labelling measures, and in certain cases even products bans, all 
entailing the prohibition to use tobacco trade marks.113  Such measures did not raise 
any doubts about their compatibility with TRIPS.114  For example, several states 
passed legislation prohibiting tobacco advertising in connection with products or 
services different from cigarettes, e.g., the ban on tobacco sponsorships in sporting 
events and motorcycle and Formula 1 races.115 
Many of these measures have been adopted pursuant to the above mentioned 
Framework Convention on Tobacco Control (“FCTC”), which defines tobacco 
advertising and promotion as “any form of commercial communication, 
recommendation or action with the aim, effect or likely effect of promoting a tobacco 
product or tobacco use either directly or indirectly.”116  The FCTC Guidelines clarify 
that designs, images, logos, trade marks, brands, colours and other names affixed on 
cigarettes packaging may also be considered tobacco advertising and promotion.117  
Under this view, plain packaging would therefore be a measure comparable to 
advertising restrictions, i.e., a measure which could be adopted by states to 
discourage smoking and achieve laudable public health objectives.118  In particular, 
                                                                                                                                                
109 See Protection of Trademarks, supra note 71, at 136, n.558. 
110 See TRIPS, supra note 60, at art. 16. 
111 See McGrady, supra note 91, at 61. 
112 Id. at 62. 
113 See, e.g., Master Settlement Agreement, available at http://ag.ca.gov/tobacco/pdf/1msa.pdf 
(last visited Mar. 25, 2011) (outlining agreement between the individual attorney generals of the 
fifty states and major American tobacco companies that placed additional restrictions on 
merchandising and event sponsorships by tobacco companies and banned billboard advertising and 
precludes tobacco products from bearing a brand name, trademark, or emblem). 
114 See, e.g., McGrady, supra note 91, at 62 (noting that in 2003 advertising restrictions 
limiting to a certain extent the use of tobacco trade marks were maintained in more than 100 WTO 
member countries). 
115 See, e.g., Council Directive 2003/33/EC, art. 5, 2003 O.J. (L152) 16, 18 (EU) (relating to the 
advertising and sponsorship of tobacco products, noting, for example, a ban on the use of tobacco 
advertising as a means of sponsorship of events); see also CORREA, supra note 61, at 200, n.109. 
116 See FCTC, supra note 14, at 4; see also Ulf Bernitz, Logo Licensing of Tobacco Products—
Can it be Prohibited?, 19 EUR. INT’L PROP. REV. 137, 137–38 (1990) (providing further examples of 
such bans). 
117 See WORLD HEALTH ORG., GUIDELINES FOR IMPLEMENTATION OF ARTICLE 13 OF THE WHO 
FRAMEWORK CONVENTION ON TOBACCO CONTROL ¶ 9 (Nov. 17–22, 2008), 
http://www.who.int/fctc/guidelines/article_13.pdf [hereinafter GUIDELINES 13]. 
118 Patricia Ferguson, Tobacco Advertising and Freedom of Speech—Why the Greater Does Not 
Include the Lesser, UNIV. C. LONDON JURISPRUDENCE REV.315, 320 (2003). 
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as shown above, the FCTC Guidelines recommend states specifically adopt plain 
packaging in order to increase the noticeability and effectiveness of health warnings 
and messages, and thus eliminate the effects of advertising and promotion on 
packaging.119  This would contribute to informing consumers about the serious 
consequences of tobacco consumption and therefore protect human health. 
A similar public interest-related argument was put forward by the European 
Court of Justice (“ECJ”) in a case involving Council Directive 2001/37/EC on the 
Manufacture, Presentation and Sale of Tobacco Products.120  In this case, the ECJ 
was asked to verify the validity of said directive, which imposes strict requirements 
on the composition and designation of cigarettes, including the need for health 
warnings on packets and the prohibition of descriptors such as “light and mild,” “low-
tar” and “ultra-light.”121  The U.K. referring court asked the ECJ to declare the 
directive invalid as it would infringe inter alia the fundamental right to property 
and/or Article 20 of TRIPS.122 
Tobacco manufacturers claimed that (i) health warnings would dominate the 
overall appearance of cigarette boxes, and therefore affect or even prevent the use of 
their trade marks, and (ii) that the prohibition on using terms such as “light,” “mild” 
and “ultra-light”—which make part of registered trade marks—would deprive them 
of valuable signs.123 
The ECJ, however, held that the above directive does not violate the 
fundamental right of property, stressing that said trade mark use restrictions that 
correspond to an objective of general interest pursued by the EU to ensure a high 
level of health protection and do not amount to a disproportionate and intolerable 
interference jeopardizing the very substance of that right.124  In other words, the ECJ 
held that the fundamental right to property, including intellectual property, is not an 
absolute right, but must be considered in relation to its social function and other 
general interests.125 
The ECJ did not specifically rule on the alleged contrariety of the directive to 
Article 20.126  Indeed, the ECJ has consistently held that the legality of an EU act 
cannot be assessed in the light of instruments of international law, like the WTO 
Agreement and TRIPS, which are not amongst the rules that it should review the 
lawfulness of acts adopted by the EU institutions.127  The ECJ clarified that it is only 
where the EU intended to implement a particular WTO obligation, or where the EU 
measure refers expressly to the precise provisions of the WTO agreements, that it is 
                                                                                                                                                
119 See GUIDELINES 11, supra note 17, ¶ 46; see also GUIDELINES 13, supra note 117, ¶¶ 15–17. 
120 See Queen v. Sec’y of State for Heath, ex parte British Am. Tobacco (investments) Ltd., 
[2002] EWHC (QB) 491 (Eng.) (indicating Council Directive 2001/37/EC, 2001 O.J. (L194) 26 (EU)). 
121 Id. ¶¶ 4, 13, 134. 
122 Id. ¶ 142. 
123 Id. ¶ 143. 
124 Id. ¶ 153. 
125 Id. ¶ 146, 149. 
126 Id. ¶¶ 154–57. 
127 See Case C-149/96, Port. Republic v. Council of the Eur. Union, 1999 E.C.R. I-8395; see also 
Case C-377/98, Kingdom of the Neth. v. Eur. Parliament & Council of the Eur. Union, 2001 E.C.R. I-
7079; Case C-301/97, Kingdom of the Neth. v. Eur. Parliament & Council of the Eur. Union, 2001 
E.C.R. I-8853; Joined Cases C-27/00 & C-122/00, Queen and Sec’y of State for the Env’t, Transport 
and the Regions, ex parte Omega Air Ltd. (c-27/00), and between Omega Air Ltd., Aero Engines Ir. 
Ltd., Omega Aviation Serv. Ltd. v. Ir. Aviation Auth. (C-122/00), 2002 E.C.R. I-2569. 
[10:450 2011] Do You Mind My Smoking? 467 
 Plain Packaging of Cigarettes Under TRIPS 
 
for the court to review the lawfulness of the EU measure in question in light of the 
WTO provisions.128 
On the one hand, one could observe that the above statements provide some 
support for the position that generic packaging regimes can be compliant with 
property rights and particularly intellectual property regimes.  Yet, on the other 
hand, the case dealt with by the ECJ, which related to health warnings and 
prohibition of descriptors, is different from plain packaging issues, which basically 
entail a restriction on the use of the “core” trade marks of tobacco manufacturers.  
Indeed, while the ECJ directive entails the prohibition on using a trade mark 
incorporating mere descriptors, the fact remains that, pursuant to the 
abovementioned decision, cigarettes producers can continue to distinguish their 
product by using their (more important) distinctive signs.129  This is not the case 
when it comes to generic packaging, as it prohibits the use of any distinctive 
elements of such signs.130 
Thus, in light of the above differences, the ECJ decision on Directive 2001/37 
may not be of great help when verifying the compliance of plain packaging with trade 
mark related provisions. 
C. TRIPS—Article 15(4) 
Article 15(4) of TRIPS states that “the nature of the goods or services to which a 
trade mark is to be applied shall in no case form an obstacle to registration of the 
trade mark” (emphasis added).131  This provision reproduces Article 7 of the Paris 
Convention.132 
By relying on the negative impact of generic packaging on brands, one could 
observe that such marketing restriction “form[s] an obstacle” to the registration and 
use of tobacco trade marks,133 and therefore would contravene Article 15(4) of 
TRIPS.134  This conclusion is based on the assumption that the use of a trade mark 
would be inextricably linked to its registration and that registration without use 
would be a “hollow formal right which is economically meaningless.”135  It has also 
                                                                                                                                                
128 See Port. Republic, 1999 E.C.R. I-8395; see also Kingdom of the Neth., 2001 E.C.R. I-8853; 
Queen & Sec’y of State for the Env’t, 2002 E.C.R. I-2569. 
129 Case C-376/98, Fed. Republic of Ger. v. Eur. Parliament & Council of the Eur. Union, 2000 
E.C.R. I-08419. 
130 Brook Grp., Ltd. v. Brown & Williamson Tobacco Corp., 509 U.S. 209, 212 (1993). 
131 TRIPS, supra note 63, at art. 15(4). 
132 Paris Convention for the Protection of Industrial Property, Mar. 20, 1888, as revised at the 
Stockholm Revision Conference, art 7, July 14, 1967, 21 U.S.T. 1538, 828 U.N.T.S. 305; TRIPS, 
supra note, 63, at art. 2(1) (stating that Articles 1 through 12 and Article 19 of The Paris Convention 
have been incorporated into TRIPS). 
133 TRIPS, supra note, 63, at art. 15(4). 
134 See ANNE MAKRIGIORGOS, THE INST. OF PATENT & TRADEMARK ATTORNEYS OF AUSTL., 
SUBMISSION TO THE SENATE COMMUNITY AFFAIRS INQUIRY INTO THE TOBACCO PACKAGING 
(REMOVING BRANDING FROM CIGARETTES PACKS) BILL 2009, at 4 (Feb. 23, 2010), http://www. 
aph.gov.au/senate/committee/clac_ctte/plain_tobacco_packaging_09/submissions/sub09.pdf. 
135 See Lalive Opinion, supra note 62, at 8. 
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been stressed that there would not be much point in obtaining the registration of 
trade marks if owners are prevented from using them in the course of trade.136 
The above argument seems to go too far and particularly confuse two concepts, 
registration and use of trade marks, which are different and autonomous.137  Indeed, 
trade mark registrations may have relevant economic value, even if the protected 
signs are not yet used.  Trade mark registrations may be assigned even where the 
underlying signs have not yet been used.138  Cases where trade mark registrations 
are purchased by companies that later decide not to use the signs in question are not 
uncommon.139  That proves that “registration” may be economically valuable and 
convenient, at least for a certain period of time, regardless of any “use” of the 
underlying sign.140 
Moreover, the real purpose of Article 15(4) is to ensure that registration can 
occur even though the use of a trade mark is not possible on a particular product, 
because the good on which it should be affixed cannot be sold on security or safety 
grounds (let’s think about a pharmaceutical product which can be marketed only 
after obtaining the relevant marketing authorization).141  Therefore, it would be 
implicit in such provision that, despite registration, the use of trade marks may be 
restricted or even prohibited by governments under certain circumstances.142  It 
could be argued that plain packaging falls within such circumstances.143 
This interpretation has also been endorsed by a former Director-General of the 
World Intellectual Property Organization (“WIPO”), which administers the Paris 
Convention: 
Article 7 [Paris Convention, which is reproduced in Article 15(4) of TRIPS] 
does not address the question of permission to use a registered mark. 
Therefore, countries party to the Paris Convention remain free to regulate 
                                                                                                                                                
136 See Morcom, supra note 58, at 21. 
137 See Mitchell, supra note 91, at 408–09. 
138 TRIPS, supra note 63, at art. 15(3). 
139 15 U.S.C. § 1063 (2006); 37 C.F.R. §§ 2.101–.107 (2010) (explaining the procedures for 
trademark registration process, including the opportunity to file an opposition); 15 U.S.C. § 1051(d); 
37 C.F.R. § 2.88 (explaining the Notice of Allowance procedure for Intent to Use applications); 37 
C.F.R. § 2.89(d) (explaining that failure to file Statement of Use within six months of issuance of the 
Notice of Allowance results in abandonment, as a matter of law); Philip K. Lyon & Jeffrey J. Look, 
How Intellectual Property Impacts a Commercial Law Practice:  Trademarks and Service Marks, 51 
ARK. L. REV. 459, 469 (1998) (explaining the procedures for registration in the event that the mark 
is not yet in use when the owner seeks registration). 
140 15 U.S.C. § 1062(b); 37 C.F.R. § 2.65 (explaining that the applicant has six months to file a 
written response to the action or the application will be abandoned). 
141 See G.H.C. BODENHAUSEN, GUIDE TO THE APPLICATION OF THE PARIS CONVENTION FOR THE 
PROTECTION OF INDUSTRIAL PROPERTY, AS REVISED AT STOCKHOLM IN 1967 128 (1968) (stressing 
that Article 7 of the Paris Convention (which is reproduced in Article 15.4 TRIPS) has a narrow 
scope of application and its purpose is to make the protection of industrial property independent of 
the question whether the relevant products may or may not be commercialized in the state in 
question). 
142 See McGrady, supra note 91, at 66–67. 
143 See Mitchell, supra note 91, at 410 (specifying that this marketing restriction would be 
compliant with the provision in question because “while the shift towards plain packaging would 
affect the ‘use’ of tobacco trademarks, the ‘registration’ of such trademarks would remain 
unaffected”). 
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the sale of certain types of goods and the fact that a mark has been 
registered for such goods does not give the right to the holder of the 
registration to be exempted from any limitation of using the mark which 
may be decided by the competent authority of the country where the mark 
is registered. 144 
In light of the above, an Article 15(4) based argument against plain packaging is 
unlikely to be accepted.  
D. Article 6 quinquies (B) of the Paris Convention 
For the sake of completeness, one also has to examine the compatibility of 
generic packaging with Article 6 quinquies (B) of the Paris Convention, which is 
incorporated by reference into TRIPS.145  This provision states that trade marks can 
be denied registration, or the latter can be invalidated, only on three specific 
grounds:  
[(i)] when they are of such a nature as to infringe rights acquired by third 
parties in the country where protection is claimed; 
[(ii)] when they are devoid of any distinctive character . . . ; 
[(iii)] when they are contrary to morality or public order and, in particular, 
of such a nature as to deceive the public.146 
In particular, Article 6 quinquies (B) of the Paris Convention might be 
interpreted as meaning that not only registration, but also the use of trade marks 
can be prevented exclusively on the above three grounds (this argument again is 
based on the assumption that the use of a trade mark would be inextricably linked to 
its registration).147  Indeed, it appears undisputed that the three reasons would not 
be motivated by their registration being problematic, but rather by the fact that the 
use of the trade mark would be problematic.148  For example, registration of a trade 
mark which violates prior exclusive rights of a third party would be denied.  This 
registration would be denied not “because the registration itself would be inherently 
wrong, but because of the harm and consumer confusion that it would cause.”149  
                                                                                                                                                
144 Neil E. Collishaw, Tobacco Control and the Paris Convention for the Protection of Industrial 
Property, 5 TOBACCO CONTROL 165, 165 (1996) (citing to a letter from A. Bogsch, former WIPO 
Director-General, to Director-General of the World Health Organization on Feb. 22, 1995); see also 
Letter from Ludwig Baeumer, Dir. Indus. Prop. Law Dept., to Ralph Oman (Aug. 31, 1994). 
145 See TRIPS, supra note 63, at art. 2(1). 
146 Paris Convention, supra note 132, at art. 6 quinquies (B). 
147 Id. at art. 6-bis; see also 15 U.S.C. § 1051(a)(3)(D) (2006) (explaining that a trademark 
application may be refused because the use of the mark would be misleading or confusing) (emphasis 
added). 
148 See 15 U.S.C. § 1051(a)(3)(D) (stressing the intended use of the mark and requirement to 
avoid misleading or confusing use). 
149 See Lalive Opinion, supra note 62, at 7. 
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Similarly, registration of a trade mark that deceives the public as to the quality and 
characteristics of the relevant products, would be refused not because the 
registration itself would be misleading, but because the concrete use of the sign 
would be misleading.150 
Therefore, WTO member countries would be able to prohibit, not only the 
registration, but also the use of trade marks only on those grounds mentioned in 
Article 6 quinquies (B).  Because those grounds do not include generic packaging,151 
however, it would follow that this marketing requirement, by prohibiting the use of 
tobacco trade marks, could contravene such provision. 
This interpretation seems again to confuse availability of trade mark rights, 
which is covered by Article 6 quinquies (B) of the Paris Convention as well as by 
Article 15(4) of TRIPS, with their enjoyment, which is instead covered by Article 16(1) 
of TRIPS.152  On the one hand, it appears undisputed that the reasons mentioned in 
Article 6 quinquies (B) (i.e., reasons for denying or invalidating registrations) “are 
not motivated by the fact that the registration itself would be problematic, but rather 
that the use of the trade mark would be.”153  For example, when a trade mark office 
rejects an application, or when a court invalidates a registration, on deceptiveness 
grounds, said office or court does so because it has assessed that the use of the trade 
mark might mislead consumers as to certain characteristics of the goods on which the 
sign in question must be affixed.  In other terms, in these administrative or judicial 
proceedings the reference to the “use” of the trade mark is useful when it comes to 
deciding whether the “registration” should be granted or invalidated.154  This does 
not mean, however, that Article 6 quinquies (B) also covers and regulates the use of 
trade marks.  Again, availability of exclusive trade mark rights, to be decided in the 
above administrative and judicial proceedings, also taking into account any possible 
use of the sign, should not be confused with the concrete use of such trade mark, 
which could even be restricted or prohibited by national governments under certain 
circumstances, regardless of the fact that the registration is still pending. 
Additionally, registration of trade marks which infringe prior rights (i.e., the 
first reason mentioned in Article 6 quinquies (B) of the Paris Convention) can be 
refused or invalidated not only because of the damages to the owners of such prior 
rights and/or the consumer confusion caused by the use of the later sign.155  Indeed 
most owners of trade marks, especially well known trade marks, are also keen in 
                                                                                                                                                
150 See, e.g., 15 U.S.C. § 1051(b)(3)(D) (explaining that the trademark applicant must verify 
that their mark, when used in commerce, will not cause confusion, mistake or deceive the consuming 
public); see generally 15 U.S.C. § 1125(a)(1) (noting prohibited uses of mark, including false or 
deceptive statements or representations that are likely to mislead and confuse consumers, will 
subject one to liability). 
151 Paris Convention, supra note 132, art. 6 quinquies (B); see also Lalive Opinion, supra note 
62, at 7 (noting that none of the above three reasons apply to tobacco trademarks and trademarks 
such as “Marlboro”, (and, likely, Philip Morris, Camel, Lucky Strike, Winston, Chesterfield) have a 
strong distinctive character and are not contrary to morality or public order, nor they are likely to 
deceive the public). 
152 Paris Convention, supra note 132, at art. 6 quinquies (B); TRIPS, supra note 63, at arts. 
15(4), 16(1). 
153 See Lalive Opinion, supra note 62, at 7. 
154 Id. 
155 Paris Convention, supra note 132, at art. 6 quinquies (B) (listing various circumstances in 
which a trade mark may be invalidated). 
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opposing the mere registration of subsequent similar signs (even where they are not 
used), as they want to maintain trade mark registers as “clean” as possible—i.e., they 
want to avoid registers that are “invaded” by similar signs, which could contribute to 
dilution of their trade marks’ uniqueness.156 
The above counter-arguments seem to have their merits and lead to the 
conclusion that Article 6-quinquies (B) cannot be interpreted as extending its scope of 
application to trade mark use, but it would cover just registration issues.  It would 
follow that plain packaging does not contravene the provision in question. 
E. Allegedly Discriminatory Aspects Contrary to TRIPS 
A possible conflict of generic packaging with TRIPS might also stem from its 
allegedly discriminatory nature.  One might observe that a country adopting this 
marketing limitation might contribute to creating a two-tier trade mark system:  (i) 
one that restricts the enjoyment of trade mark rights in the tobacco industry and (ii) 
another system giving all other trade marks the broader protection guaranteed by 
TRIPS.157  The result would be an unlawful discriminatory treatment of tobacco 
trade marks. 
It should also be noted that TRIPS provisions on trade marks, unlike those on 
patents, do not expressly forbid discriminatory treatments.158  As far as availability 
of patent rights is concerned, Article 27(1) of TRIPS states that patents must be 
“available for any inventions . . . in all fields of technology” (emphasis added).159  Yet 
a similar rule is not contained in trade mark-related provisions, Articles 15 to 21.160  
By relying on this argument, it would follow that the TRIPS principle of non-
discrimination between fields of technology applies just to patents but not to trade 
marks, and therefore generic packaging which restricts the use of trade marks in just 
a specific field—i.e., tobacco industry—would be lawful. 
In any case, even assuming that a principle of non-discrimination between fields 
of technology applies to trade marks, plain packaging might still be considered non-
discriminatory.  Indeed, one could observe that this measure boils down into a lawful 
differential treatment, i.e., restriction on use of tobacco trade marks, which is made 
necessary to meet socially sensitive targets in a specific field.161  The distinction 
between unlawful “discrimination” and lawful “differential treatment” in the field of 
IPRs has already been stressed by the WTO Panel in Canada—Patent Protection for 
Pharmaceutical Products.162  In this case, the Panel stated that “Article 27 does not 
prohibit bona fide exceptions to deal with problems that may exist only in certain 
                                                                                                                                                
156 Panavision Int’l., L.P. v. Toeppen, 945 F. Supp. 1296, 1301 (C.D. Cal. 1996). 
157 Lalive Opinion, supra note 62, at 6. 
158 Compare, TRIPS, supra note 63, art. 15 (stating that “any sign . . . capable of distinguishing 
the goods or services of one undertaking from those of other undertakings, shall be capable of 
constituting a trade mark.”), with TRIPS, supra note 63, art. 27 (stating that “patents shall be 
available and patented rights enjoyable without discrimination as to the place of invention”) 
(emphasis added). 
159 TRIPS, supra note 63, art. 27(1). 
160 See generally TRIPS, supra note 63, arts. 15–21. 
161 Canada—Patent, supra note 65, at 19. 
162 Id. at 105. 
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product areas.”163  In this respect, a leading scholar pointed out that “[i]f specific 
rules applicable only to pharmaceutical patents are necessary to address important 
public interests such as the protection of public health, this does not constitute 
‘discrimination’ against the field of pharmaceutical technology.  It constitutes 
recognition of legitimate public interests in differential treatment.”164  Such 
statement has been made in relation to pharmaceutical patents, but it might also be 
invoked when it comes to interpreting TRIPS trade mark-related provisions and to 
applying them to plain packaging of cigarettes.  Indeed this marketing measure is 
meant to meet socially relevant aims in the public health field, especially reduction of 
smoking uptake.165 
F. TRIPS—Article 8(1) 
Would it be possible to justify generic packaging under Article 8(1) of TRIPS? 
 
This provision states that “[m]embers may, in formulating or amending their 
laws and regulations, adopt measures necessary to protect public health and 
nutrition, and to promote the public interest in sectors of vital importance to their 
socio-economic and technological development, provided that such measures are 
consistent with the provisions of this Agreement.”166 
It must be preliminarily noted that a WTO Member state seeking to adopt a 
measure (e.g., a public health measure) pursuant to Article 8(1) should prove that 
this is (i) necessary to promote the public interest in sectors of vital importance (e.g., 
to protect human health) and (ii) consistent with TRIPS.167 
The first requirement, i.e., a necessity test, is two-fold.  First, there should be a 
causal link between the measure and the protection of the specific public interest.168  
Second, the measure should be the least restrictive on IPRs.169 The scope of this 
provision is further limited by the second requirement, i.e., that the measure be 
consistent with TRIPS.170  This confirms that Article 8(1) does not grant a right to 
override TRIPS obligations in order to protect public interests such as human 
health.171  It just serves as a tool to interpret TRIPS, rather than being an exception 
to its application.172  Article 8(1) of TRIPS is therefore different from other WTO 
provisions such as GATT Article XX and GATS Article XIV, which constitute 
exceptions to those agreements and allow states to contravene their provisions (e.g., 
                                                                                                                                                
163 Id. at 170–71. 
164 See FREDERICK ABBOTT, FRIENDS WORLD COMM. FOR CONSULTATION QUAKER UNITED 
NATIONS OFFICE—GENEVA COMPULSORY LICENSING FOR PUBLIC HEALTH NEEDS:  THE TRIPS 
AGENDA AT THE WTO AFTER THE DOHA DECLARATION ON PUBLIC HEALTH 50 (2002), 
http://www.cptech.org/ip/health/cl/quno-op9.pdf. 
165 See Fagen v. Axelrod, 550 N.Y.S.2d 552, 557 (N.Y. App. Div. 1990) (noting that smoking is 
the largest single preventable cause of premature death and disability in the United States). 
166 TRIPS, supra note 63, art. 8(1). 
167 Id. art. 8. 
168 Lalive Opinion, supra note 62, at 13. 
169 Id.; see also Correa, supra note 61, at 108. 
170 Lalive Opinion, supra note 62, at 13. 
171 Id. at 13–14. 
172 Id. at 14; see also Gervais, supra note 61, at 209. 
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GATT Article XX(b) permits countries to adopt measures necessary to protect human 
health, inter alia).173 
Yet, plain packaging could fail the above mentioned causal link requirement.  
Because of the uncertainty surrounding its inherent ability and effectiveness to 
reduce the incidence of smoking,174 it might be difficult for states seeking to adopt 
generic packaging to prove the link between such measure and the protection of 
public health.  Plain packaging would also seem unlikely to satisfy the necessity test 
for the following reason:  there might be other means to pursue the same public 
health objective, which are more effective and less restrictive of IPRs, such as 
educational campaigns, health information and warnings, and advertising 
restrictions.175 
Finally, the second condition of Article 8(1) would not be easy to meet and a 
Panel’s decision finding generic packaging contrary to one of the above analyzed 
TRIPS provisions cannot be ruled out.176 
It goes without saying that states seeking to adopt plain packaging may 
overcome the above mentioned difficulties should they succeed in proving (a) the 
existence of the causal link between the measure and the protection of public health, 
by relying on studies confirming that this measure would make cigarette boxes less 
attractive to consumers and health warnings and information more visible and 
accordingly increase the incidence of smoking cessation;177 and (b) that no less trade 
restrictive means of achieving the chosen policy goal exist.  In addition, states should 
also prove that plain packaging is compliant with the above TRIPS provisions.  In 
this respect, particular weight should be attached to both Article 8(1) of TRIPS and 
paragraph 4 of the 2001 Doha Declaration on the TRIPS Agreement and Public 
Health.  The latter reproduces the spirit of the former by stressing that “the TRIPS 
Agreement does not and should not prevent members from taking measures to 
protect public health.”178 
States seeking to adopt plain packaging could justify this marketing restriction 
by stressing that each country has the right to decide the level of health protection 
                                                                                                                                                
173 See CARLOS CORREA, WORLD HEALTH ORG., IMPLICATIONS OF THE DOHA DECLARATION ON 
THE TRIPS AGREEMENT AND PUBLIC HEALTH 9 (June 2002), http://whqlibdoc.who.int/hq/2002/ 
who_edm_par_2002.3.pdf; Abbott, supra note 164, at 24–25 (2001). 
174 See IMPERIAL TOBACCO AUSTL. LTD., supra note 30, at 17. 
175 Id. at 4, 17–18 (providing examples of less restrictive programs that have been implemented 
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176 See also Lalive Opinion, supra note 62, at 13–14. 
177 Freeman, Chapman & Rimmer, supra note 1, at 587 (promoters of generic packaging refuse 
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Image?  An Experimental Study, 17 TOBACCO CONTROL 416, 419–20 (2008). 
178 World Trade Organization, Ministerial Declaration of 14 November 1998, 
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which it considers appropriate in a given situation,179 as it has also been stated by 
the WTO Panel in EC—Asbestos.180  Reference can also be made to the GATT Panel 
decision in Thailand—Restrictions on Importation of and Internal Taxes on 
Cigarettes.181  In that pre-WTO case the Panel held that smoking amounts to a 
“serious risk to human health” and, accordingly, measures aimed at reducing the 
consumption of cigarettes fall within the scope of GATT Article XX(b).182  In that 
decision, the Panel noted that the latter provision permits states to give priority to 
the human health protection over trade liberalization.183  Moreover, although the 
Thai measures in question were finally considered as discriminatory and not in 
conformity with the necessity test enshrined in GATT Article XX(b), the Panel held 
that Thailand could take other measures to limit the health consequences of 
cigarettes liberalization, such as taxes on tobacco products, advertising bans and 
labelling requirements.184  This finding thus recognized the priority of public health 
policy over trade liberalization and marketing freedom, particularly of cigarettes, 
showing that tobacco policies, if implemented in a non-discriminatory way, may be in 
conformity with GATT provisions and generally with international trade rules.185 
CONCLUSION 
As illustrated by the above analysis, plain packaging is a thorny issue that will 
keep IPRs and WTO specialists as well as academics busy in the years to come.  
Packaging is not only one form of advertising for the tobacco industry,186 but in most 
jurisdictions—due to the increasing number of advertising restrictions—it is the 
ultimate form of advertising for tobacco products.  Because this is an as yet untried 
form of an anti-tobacco tool, an interesting war of conflicting evidence, contradictory 
expertise and diverging narratives is currently surrounding the discussion about its 
implementation.187  In particular, given the lack of data on previous use, it does not 
seem possible to determine how consumers may react, but only how consumers say 
they will react.188 
In opposing this new strategy, the tobacco industry is particularly keen on 
emphasizing both the uselessness of plain packaging in reducing smoking rates and 
                                                                                                                                                
179 See also Mark Davison, Professor & Faculty of Law at Monash Univ., Plain Packaging of 
Cigarettes, Address at the Intellectual Property Research Institute of Australia Seminar Melbourne 
(May 26, 2010) (on file with the John Marshall Review of Intellectual Property Law). 
180 See Appellate Body Report, European Communities—Measures Affecting Asbestos and 
Asbestos-Containing Products, ¶ 168, WT/DS135/AB/R, (Apr. 5, 2001). 
181 See generally Panel Report, Thailand—Restrictions on Importation and Internal Taxes on 
Cigarettes, DS10/R–37S/200 (Oct. 5, 1990). 
182 Id. at 20. 
183 Id. 
184 See id. at 20. 
185 See also Valentina S. Vadi, Trade Mark Protection, Public Health and International 
Investment Law:  Strains and Paradoxes, 20 EUR. J. INT’L L.773, 789 (2009). 
186 Michael Gershman, Packaging Positioning Tool of the 1980s, 76 MGMT. REV. 33, 33 (1987). 
187 See generally Alberto Alemanno & Enrico Bonadio, The Case of Plain Packaging for 
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Tobacco Products, supra note 35, at 76. 
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its incompatibility with TRIPS provisions on trade marks.  Clearly, major tobacco 
companies fear to lose a powerful means of communication between them and 
consumers and are afraid that what they see as a serious curtailment of their trade 
mark, trade-dress and goodwill-related rights could hit hard their flourishing 
businesses and decrease cigarettes sales.  Indeed, it is a fact that sales of tobacco 
products continue to decline in the industrialized and increase in the developing 
world.  For example, the WHO found that in the United States smoking rates shrunk 
by nearly half in thirty years (from the 1960s to 1990s), falling to twenty-three 
percent of adults by 1997 and in the developing world tobacco consumption is rising 
by 3.4 percent per year.189 
On the other hand, those who support plain packaging stress its enormous 
potential in the fight against tobacco-related diseases and defend its legality and 
conformity with WTO law and particularly with TRIPS provisions protecting trade 
marks and public health.  To their eyes, plain packaging is both useful and lawful. 
Given the high economic stakes related to the introduction of plain packaging 
and the impact such measures could have on tobacco consumption and eventually on 
other regulated sectors, it is not unlikely that states adopting such a marketing 
restriction would expose themselves to a WTO dispute settlement proceedings or to 
claims of “investor state” protection within the framework of bilateral investments 
treaties (“BITs”).190  Needless to say, such actions might be triggered by countries 
particularly keen on protecting their tobacco majors or, within the context of a BIT’s 
dispute, by the companies themselves.  As illustrated by the analysis, the outcome of 
such disputes would be far from predictable. 
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